The response to methylene blue in patients with severe hypotension during liver transplantation

Journal of Clinical Anesthesia

Volumn 24, Issue 4, 2012, Pages 324-328

  Cheng, Sara S ^a   Berman, Gregory W ^a   Merritt, Glenn R ^b   Hendrickse, Adrian ^a   Fiegel, Matthew J ^a   Teitelbaum, Isaac ^a   Campsen, Jeffrey ^c   Wachs, Michael ^d   Zimmerman, Michael ^d   Mandell, M Susan ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Hypotension; Methylene blue; Orthotopic liver transplantation; Shock

Indexed keywords

ADRENALIN; ATROPINE; BICARBONATE; CALCIUM CHLORIDE; CATECHOLAMINE; CEFTRIAXONE; DOBUTAMINE; ESOMEPRAZOLE; ETIRACETAM; FUROSEMIDE; INSULIN; LACTULOSE; METHYLENE BLUE; N ACETYLGLUCOSAMINE; NORADRENALIN; PANTOPRAZOLE; PROPRANOLOL; RIFAXIMIN; SPIRONOLACTONE;

ADULT; CASE REPORT; DIALYSIS; DISEASE SEVERITY; DRUG INFUSION; FEMALE; GENERAL ANESTHESIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

EID: 84861176827     PISSN: 09528180     EISSN: 18734529     Source Type: Journal    
DOI: 10.1016/j.jclinane.2011.10.010     Document Type: Article

References (27)

1. Riha H, and Augoustides JG Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery J Cardiothorac Vasc Anesth 25 2011 736 738
2. Levin RL, Degrange MA, and Bruno GF Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery Ann Thorac Surg 77 2004 496 499
3. Preiser JC, Lejeune P, and Roman A Methylene blue administration in septic shock: a clinical trial Crit Care Med 23 1995 259 264
4. Daemen-Gubbels CR, Groeneveld PH, Groeneveld AB, van Kamp GJ, Bronsveld W, and Thijs LG Methylene blue increases myocardial function in septic shock Crit Care Med 23 1995 1363 1370
5. Midgley S, Grant IS, Haynes WG, and Webb DJ Nitric oxide in liver failure Lancet 338 8782-8783 1991 1590
6. Fischer GW, Bengtsson Y, Scarola S, and Cohen E Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation J Cardiothorac Vasc Anesth 24 2010 463 466
7. Cao Z, Gao Y, and Tao G Vasoplegic syndrome during liver transplantation Anesth Analg 108 2009 1941 1943
8. Mayer B, Brunner F, and Schmidt K Inhibition of nitric oxide synthesis by methylene blue Biochem Pharmacol 45 1993 367 374
9. Mayer B, Brunner F, and Schmidt K Novel actions of methylene blue Eur Heart J 14 Suppl 1 1993 22 26
10. Shanmugam G Vasoplegic syndrome-the role of methylene blue Eur J Cardiothorac Surg 28 2005 705 710
11. Brady AJ, Poole-Wilson PA, Harding SE, and Warren JB Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia Am J Physiol 263 6 Pt 2 1992 H1963 H1966
12. Kumar A, Brar R, and Wang P Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility Am J Physiol 276 1 Pt 2 1999 R265 276
13. Hori N, Okanoue T, and Mori T Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis Clin Exp Pharmacol Physiol 23 1996 30 35
14. Schneider F, Lutun P, Boudjema K, Wolf P, and Tempé JD In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure Hepatology 19 1994 38 44
15. Speziale G, Ruvolo G, and Marino B A role for nitric oxide in the vasoplegic syndrome J Cardiovasc Surg (Torino) 37 1996 301 303
16. Jones JD, Carney ST, Vrana KE, Norford DC, and Howlett AC Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells Neuropharmacology 54 2008 23 30
17. Batkai S, and Pacher P Endocannabinoids and cardiac contractile function: pathophysiological implications Pharmacol Res 60 2009 99 106
18. Ripoll C, Yotti R, Bermejo J, and Banares R The heart in liver transplantation J Hepatol 54 2011 810 822
19. Bezinover D, McQuillan P, Rossignol J, Uemura T, Kadry Z, and Janicki P Vasoplegic shock during liver transplantation: is the preoperative cGMP plasma level a potential predictor of hemodynamic instability? Med Sci Monit 16 2010 CS114 7
20. Koelzow H, Gedney JA, Baumann J, Snook NJ, and Bellamy MC The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation Anesth Analg 94 2002 824 829
21. Williams JW, Vera S, and Peters TG Cholestatic jaundice after hepatic transplantation. A nonimmunologically mediated event Am J Surg 151 1986 65 70
22. Paugam-Burtz C, Kavafyan J, and Merckx P Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors Liver Transpl 15 2009 522 529
23. Noris M, Todeschini M, and Casiraghi F Effect of acetate, bicarbonate dialysis, and acetate-free biofiltration on nitric oxide synthesis: implications for dialysis hypotension Am J Kidney Dis 32 1998 115 124
24. Peer G, Itzhakov E, and Wollman Y Methylene blue, a nitric oxide inhibitor, prevents haemodialysis hypotension Nephrol Dial Transplant 16 2001 1436 1441
25. DiSanto AR, and Wagner JG Pharmacokinetics of highly ionized drugs. II. Methylene blue-absorption, metabolism, and excretion in man and dog after oral administration J Pharm Sci 61 1972 1086 1090
26. Peter C, Hongwan D, Kupfer A, and Lauterburg BH Pharmacokinetics and organ distribution of intravenous and oral methylene blue Eur J Clin Pharmacol 56 2000 247 250
27. Paciullo CA, McMahon Horner D, Hatton KW, and Flynn JD Methylene blue for the treatment of septic shock Pharmacotherapy 30 2010 702 715